Vernon Bernardino
Stock Analyst at HC Wainwright & Co.
(3.15)
# 1,086
Out of 4,695 analysts
184
Total ratings
26.32%
Success rate
8.3%
Average return
Main Sectors:
Stocks Rated by Vernon Bernardino
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NVAX Novavax | Reiterates: Buy | $19 | $8.83 | +115.26% | 22 | Dec 10, 2024 | |
| ARTL Artelo Biosciences | Reiterates: Buy | $5 | $1.08 | +365.12% | 10 | Dec 9, 2024 | |
| WINT Windtree Therapeutics | Reiterates: Neutral | $7 | $0.36 | +1,852.58% | 2 | Dec 4, 2024 | |
| SAVA Cassava Sciences | Downgrades: Neutral | $116 | $2.81 | +4,028.26% | 22 | Nov 26, 2024 | |
| NRXP NRx Pharmaceuticals | Reiterates: Buy | $19 | $1.20 | +1,483.33% | 5 | Nov 25, 2024 | |
| ELDN Eledon Pharmaceuticals | Reiterates: Buy | $16 | $4.70 | +240.43% | 9 | Nov 20, 2024 | |
| GOVX GeoVax Labs | Reiterates: Buy | $8 | $2.40 | +233.33% | 14 | Nov 20, 2024 | |
| CRDL Cardiol Therapeutics | Reiterates: Buy | $9 | $1.38 | +552.46% | 6 | Nov 20, 2024 | |
| HUMA Humacyte | Reiterates: Buy | $12 | $4.18 | +187.43% | 4 | Nov 18, 2024 | |
| CADL Candel Therapeutics | Reiterates: Buy | $11 | $6.89 | +59.65% | 4 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $2 | $0.35 | +464.02% | 8 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $0.37 | +1,817.81% | 6 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $6 | $1.59 | +277.36% | 7 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $100 | $3.07 | +3,156.27% | 9 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18 | $1.58 | +1,039.24% | 5 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $21 | $1.90 | +1,005.26% | 10 | Aug 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $36 | $2.65 | +1,258.49% | 5 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $0.36 | +2,696.42% | 1 | Jan 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $45 | $2.54 | +1,671.65% | 1 | Dec 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $1.58 | +1,165.82% | 4 | May 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $550 → $100 | $0.17 | +59,423.81% | 2 | May 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $175,000 → $15,750 | $4.85 | +324,642.27% | 3 | Mar 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $0.88 | +2,756.82% | 8 | Mar 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $240 | $16.77 | +1,331.06% | 4 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $80 | $0.77 | +10,243.94% | 1 | Oct 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $100 | $0.83 | +12,019.74% | 1 | Jun 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $8,000 | $5.96 | +134,047.16% | 1 | Dec 29, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $7 | $4.04 | +73.48% | 2 | Aug 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $75 → $30 | $3.14 | +855.41% | 1 | Mar 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $40 | $4.31 | +829.15% | 1 | Feb 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $0.66 | +2,648.09% | 1 | Jan 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $1.96 | +155.10% | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $1,440 | $4.10 | +35,021.95% | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $24 | $50.48 | -52.46% | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $3,420 | $3.01 | +113,710.32% | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $19,000 | $7.51 | +252,896.01% | 1 | Oct 6, 2017 |
Novavax
Dec 10, 2024
Reiterates: Buy
Price Target: $19
Current: $8.83
Upside: +115.26%
Artelo Biosciences
Dec 9, 2024
Reiterates: Buy
Price Target: $5
Current: $1.08
Upside: +365.12%
Windtree Therapeutics
Dec 4, 2024
Reiterates: Neutral
Price Target: $7
Current: $0.36
Upside: +1,852.58%
Cassava Sciences
Nov 26, 2024
Downgrades: Neutral
Price Target: $116
Current: $2.81
Upside: +4,028.26%
NRx Pharmaceuticals
Nov 25, 2024
Reiterates: Buy
Price Target: $19
Current: $1.20
Upside: +1,483.33%
Eledon Pharmaceuticals
Nov 20, 2024
Reiterates: Buy
Price Target: $16
Current: $4.70
Upside: +240.43%
GeoVax Labs
Nov 20, 2024
Reiterates: Buy
Price Target: $8
Current: $2.40
Upside: +233.33%
Cardiol Therapeutics
Nov 20, 2024
Reiterates: Buy
Price Target: $9
Current: $1.38
Upside: +552.46%
Humacyte
Nov 18, 2024
Reiterates: Buy
Price Target: $12
Current: $4.18
Upside: +187.43%
Candel Therapeutics
Nov 18, 2024
Reiterates: Buy
Price Target: $11
Current: $6.89
Upside: +59.65%
Nov 15, 2024
Reiterates: Buy
Price Target: $2
Current: $0.35
Upside: +464.02%
Nov 15, 2024
Reiterates: Buy
Price Target: $7
Current: $0.37
Upside: +1,817.81%
Nov 14, 2024
Reiterates: Buy
Price Target: $6
Current: $1.59
Upside: +277.36%
Nov 12, 2024
Reiterates: Buy
Price Target: $100
Current: $3.07
Upside: +3,156.27%
Nov 12, 2024
Reiterates: Buy
Price Target: $18
Current: $1.58
Upside: +1,039.24%
Aug 20, 2024
Reiterates: Buy
Price Target: $21
Current: $1.90
Upside: +1,005.26%
May 14, 2024
Reiterates: Buy
Price Target: $36
Current: $2.65
Upside: +1,258.49%
Jan 30, 2024
Initiates: Buy
Price Target: $10
Current: $0.36
Upside: +2,696.42%
Dec 14, 2023
Initiates: Buy
Price Target: $45
Current: $2.54
Upside: +1,671.65%
May 31, 2023
Reiterates: Buy
Price Target: $20
Current: $1.58
Upside: +1,165.82%
May 25, 2023
Maintains: Buy
Price Target: $550 → $100
Current: $0.17
Upside: +59,423.81%
Mar 31, 2023
Reiterates: Buy
Price Target: $175,000 → $15,750
Current: $4.85
Upside: +324,642.27%
Mar 8, 2023
Reiterates: Buy
Price Target: $25
Current: $0.88
Upside: +2,756.82%
Mar 7, 2023
Reiterates: Buy
Price Target: $240
Current: $16.77
Upside: +1,331.06%
Oct 7, 2022
Initiates: Buy
Price Target: $80
Current: $0.77
Upside: +10,243.94%
Jun 30, 2021
Initiates: Buy
Price Target: $100
Current: $0.83
Upside: +12,019.74%
Dec 29, 2020
Initiates: Buy
Price Target: $8,000
Current: $5.96
Upside: +134,047.16%
Aug 26, 2020
Maintains: Buy
Price Target: $4 → $7
Current: $4.04
Upside: +73.48%
Mar 11, 2020
Reiterates: Buy
Price Target: $75 → $30
Current: $3.14
Upside: +855.41%
Feb 25, 2020
Initiates: Buy
Price Target: $40
Current: $4.31
Upside: +829.15%
Jan 13, 2020
Initiates: Buy
Price Target: $18
Current: $0.66
Upside: +2,648.09%
Oct 6, 2017
Initiates: Buy
Price Target: $5
Current: $1.96
Upside: +155.10%
Oct 6, 2017
Initiates: Buy
Price Target: $1,440
Current: $4.10
Upside: +35,021.95%
Oct 6, 2017
Initiates: Buy
Price Target: $24
Current: $50.48
Upside: -52.46%
Oct 6, 2017
Initiates: Buy
Price Target: $3,420
Current: $3.01
Upside: +113,710.32%
Oct 6, 2017
Initiates: Buy
Price Target: $19,000
Current: $7.51
Upside: +252,896.01%